60 Minutes Showcases Potential of DNA and Genetic Genealogy; Opportunity for Crypto Investors
Throughout the years, 60 Minutes has been responsible for reporting on some of the biggest stories in the world. Many of the most memorable episodes have involved world leader interviews, stories on endangered animals, profiles of famous celebrities, and occasionally, segments on promising developments in business and science. A week ago, 60 Minutes had a very interesting report on how the authorities used Genetic genealogy to solve the case of the Golden State Killer, and how the authorities plan to keep using this new field to solve more cold cases in the future.
On April 25, 2018, authorities in Sacramento announced that they had solved the notorious case of the Golden State Killer. Authorities were able to use a promising new technique called Genetic genealogy to help identify 72-year-old former police officer, Joseph DeAngelo, as the suspected killer.
Genetic genealogy is a mixture of high-tech DNA analysis, high speed computer technology, and family genealogy. The end goal is to determine the level and type of genetic relationship between individuals.
In the case of the Golden State Killer, DNA came into play because the killer had committed at least 12 murders, 50 rapes, and many home burglaries. Investigators were able to obtain DNA from the killer at one of the reported crime scenes. After many years of frustrating dead ends, a cold case investigator submitted the obtained DNA sample to GEDmatch. GEDmatch is the largest public genealogy database in the world. After uploading the sample, authorities were able to generate a handful of leads which eventually led to the front doors of Joseph DeAngelo.
In addition to the Golden State Killer case, authorities have used Genetic genealogy to make arrests in at least 11 other cold cases. While the science appears to be sound, there is a legal question that has yet to be answered. There is no doubt that attorneys for the accused will raise the question of privacy and whether using databases, thought to be private, should be legal.
Opportunity for Crypto Investors
While I’ve invested in equities and crypto for many years with varying degrees of success, I’ve never had the opportunity to invest at the beginning of a new frontier. Fortunately, the opportunity has come. Encrypgen (DNA) is a genomic blockchain network that provides customers and partners with best-in-class, next generation, blockchain security for protecting, sharing and re-marketing genomic data. This creates a fair marketplace for a person’s DNA that can be stored private and sold (if a person wishes to do that).
Over the past few months, Encrypgen has been gaining attention in the mainstream media because of their revolutionary technology as well as the fact that their closest competition is still years away.
In August, Encrypgen released a beta version of its Gene-Chain. The Gene-Chain allows consumers to upload their genetic profile and for researchers to purchase that genetic data. Within the next 2 weeks, the company plans to release the full version of the Gene-Chain which will officially make them a new pioneer in the field of genomic blockchain security.
With the DNA token hovering at approximately 5 cents, the time is running out to accumulate at bargain basement prices. I fully expect the token to achieve utility in the next several months which will cause a rocket-like explosion in the token price. There is no looking back now, only forward, and I love what I see.
Featured image courtesy of Shutterstock.